poisar

Stocks · News reference

Guardant Health Announces Publication of PRECISION Study Results in ESMO Open

Fiscal.ai

Guardant Health reported that the journal ESMO Open has published results from the PRECISION study, which evaluated blood-based approaches for assessing recurrence risk in colorectal cancer patients.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — Guardant Health, Inc. (GH)

    Filed: 2026-11-16 AccNo: 0001193125-26-463573 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 3.02: Unregistered Sales of Equity Securities Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits